In order to search for AHR ligands that could be used to prevent or treat NEC when administered during pregnancy, we next screened a clinical compound library containing FDA-approved drugs33 using an AHR-luciferase reporter intestinal epithelial cell line as described in Methods. This evidence concerns the gene AHR and necrotizing enterocolitis.